Madorra wins FDA breakthrough nod for home vulvovaginal atrophy treatment device
Madorra this week said it has received FDA breakthrough device designation for its noninvasive, home-use device for moderate to severe vulvovaginal atrophy. Read More →
Nutromics won in the category of ‘Technology Platform Solution of the Year’ at the AIIA’s 2021 national iAwards!
We are excited to announce that last night Nutromics won in the category of 'Technology Platform Solution of the Year' at the AIIA's 2021 national iAwards! Read More →
InBrace Raises $102M Series D Financing
InBrace, the orthodontic company behind the novel Smartwire™ category of behind-the-teeth, teeth straightening, today announced the closing of an oversubscribed $102 million Series D financing by funds affiliated with new investor groups co-led by Farallon Capital Management, L.L.C. and Marshall Wace. Read More →
Stryker Acquires Med Device Company Gauss Surgical
Stryker today announced the acquisition of Gauss Surgical, a Menlo Park, CA-based medical device company that has developed Triton™, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery. Read More →
Sentien Biotechnologies Partners with BARDA to Evaluate High Dose Cohort in Phase 1/2 Trial of SBI-101 for Treatment of Acute Kidney Injury Associated with Sepsis
Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, today announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA). Read More →
Onkos Surgical raises $15M Series C
Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopedic procedures based in Parsippany, announced Wednesday that it has raised $15 million in Series C funding from its existing investor syndicate. Read More →
Australian medtech startup Nutromics bags $4M in pre-market funding for continuous molecular monitoring device
Nutromics, an Australian medical technology startup, has raised A$5.7 million ($4.1 million) in a pre-market funding round participated by private investors. This brings its total capital raised in the past three years to A$10 million ($7.2 million). Read More →
Eclipse Regenesis Awarded National Institutes of Health (NIH) Grant
Eclipse Regenesis, Inc., developer of the first restorative therapy to address pediatric and adult Short Bowel Syndrome, has been awarded a National Institutes of Health Small Business Innovation Research (NIH SBIR) Fast Track grant of $1.7 million. Read More →
Genetesis Announces New Scientific Advisory Board
Genetesis, the market leader in the design, development and commercialization of biomagnetic imaging solutions, today announced its new Scientific Advisory Board (SAB). Read More →
Trinity Health Mid-Atlantic teams with NeuroFlow to offer mental health app to workers
Independence Blue Cross Foundation is teaming up with Trinity Health Mid-Atlantic and health tech company NeuroFlow to support its workers’ mental health. Read More →